Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_1
4
57%
Ph not_applicable
1
14%
Ph phase_2
2
29%

Phase Distribution

4

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
4(57.1%)
Phase 2Efficacy & side effects
2(28.6%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(2)
Terminated(2)
Other(3)

Detailed Status

unknown3
Completed2
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Phase 14 (57.1%)
Phase 22 (28.6%)
N/A1 (14.3%)

Trials by Status

completed229%
withdrawn114%
unknown343%
terminated114%

Recent Activity

0 active trials
Showing 5 of 7
completedphase_1

Stem Cell Treatment of Peyronie´s Disease.

NCT04771442
terminatedphase_2

Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic Sclerosis

NCT02558543
withdrawnphase_1

Stromal Vascular Fraction for Treatment of Xerostomia

NCT03061110
completednot_applicable

Safety Analysis of Implantation of Stromal Vascular Fraction

NCT03226093
unknownphase_1

The Effect of Autologous Stromal Vascular Fractions on Skin Regeneration

NCT03189628
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT04771442Phase 1

Stem Cell Treatment of Peyronie´s Disease.

Completed
NCT02558543Phase 2

Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic Sclerosis

Terminated
NCT03061110Phase 1

Stromal Vascular Fraction for Treatment of Xerostomia

Withdrawn
NCT03226093Not Applicable

Safety Analysis of Implantation of Stromal Vascular Fraction

Completed
NCT03189628Phase 1

The Effect of Autologous Stromal Vascular Fractions on Skin Regeneration

Unknown
NCT02866552Phase 2

SCLERoderma et Adipose-DErived Stroma Cells

Unknown
NCT02546882Phase 1

The Improving Effect of Autologous Stromal Vascular Fraction (SVF) in Adipose Tissue on Skin Grafting

Unknown

All 7 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
7